Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis (Q44697151)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2013

Language	Label	Description	Also known as
English	Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis	scientific article published in April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

5 December 2017

0 references

steatohepatitis

0 references

14

1 reference

Europe PubMed Central

5 December 2017

Lars P. Bechmann

object named as

Lars P Bechmann

1

0 references

author name string

Peri Kocabayoglu

2

1 reference

Europe PubMed Central

5 December 2017

Jan-Peter Sowa

3

1 reference

Europe PubMed Central

5 December 2017

Svenja Sydor

4

1 reference

Europe PubMed Central

5 December 2017

Jan Best

5

1 reference

Europe PubMed Central

5 December 2017

Martin Schlattjan

6

1 reference

Europe PubMed Central

5 December 2017

Anja Beilfuss

7

1 reference

Europe PubMed Central

5 December 2017

Johannes Schmitt

8

1 reference

Europe PubMed Central

5 December 2017

Rebekka A Hannivoort

9

1 reference

Europe PubMed Central

5 December 2017

Alpaslan Kilicarslan

10

1 reference

Europe PubMed Central

5 December 2017

Christian Rust

11

1 reference

Europe PubMed Central

5 December 2017

Frieder Berr

12

1 reference

Europe PubMed Central

5 December 2017

Oliver Tschopp

13

1 reference

Europe PubMed Central

5 December 2017

Scott L Friedman

15

1 reference

Europe PubMed Central

5 December 2017

Andreas Geier

16

1 reference

Europe PubMed Central

5 December 2017

Ali Canbay

17

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 April 2013

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

57

1 reference

Europe PubMed Central

5 December 2017

1394-1406

1 reference

Europe PubMed Central

5 December 2017

4

1 reference

Europe PubMed Central

5 December 2017

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Novel insights into the pathophysiology of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acid levels are increased in the liver of patients with steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatic injury induced by bile salts: correlation between biochemical and morphological events

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile salts and cholestasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile salt transporters: molecular characterization, function, and regulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The interaction of hepatic lipid and glucose metabolism in liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Pathogenesis of non-alcoholic steatohepatitis: human data

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Enterohepatic bile salt transporters in normal physiology and liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Mitochondrial membrane perturbations in cholestasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Adiponectin and its receptors in non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Impaired liver regeneration of steatotic rats after portal vein ligation: a particular emphasis on (99m)Tc-DISIDA scintigraphy and adiponectin signaling.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

A Prospective Morphologic Evaluation of Hepatic Toxicity of Chenodeoxycholic Acid in Patients with Cholelithiasis: The National Cooperative Gallstone Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26225

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44697151&oldid=2032833479"